MR spectroscopy glutamate measures reflect craving for heroin in addicts
New MR spectroscopy findings indicate that changes in brain glutamate levels reflect changes in heroin craving among addicts during methadone maintenance therapy. MRS may eventually help predict whether addicts will relapse after treatment.
New MR spectroscopy findings indicate that changes in brain glutamate levels reflect changes in heroin craving among addicts during methadone maintenance therapy. MRS may eventually help predict whether addicts will relapse after treatment.
Animal studies have previously shown that glutamate is involved in the development and expression of drug addiction. Drug exposure and withdrawal change the glutamate levels in the anterior cingulate cortex, ventral striatum, thalamus, and hippocampus.
Dr. Mark Greenwald and colleagues at Wayne State University established for the first time that glutamate changes can be measured in humans. Their data demonstrate a significant correlation between glutamate levels and heroin craving during methadone detoxification therapy.
Six heroin addicts aged 31 to 55 years and healthy age-matched controls participated in the study.
Baseline H-1 MR spectroscopic scans were completed several days after the start ofa methadone treatment regimen. Follow-up MRS evaluations were performed about one month after the baseline scan.All patients showed significantly lower glutamate levels in the anterior cingulate while they received the high methadone dosage than during lower dose administrations (p
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
